Delivering Pharma Value: Where Is the Optimal Home for Health Economics and Outcomes Research (HEOR)?
Speakers
Betsy J Lahue, MPH, Alkemi, Manchester Center, VT, United States; Shuvayu Sen, PhD, Merck & Co., Rahway, NJ, United States
Pharmaceutical companies often restructure HEOR functions for strategic impact, but where does HEOR truly belong? Competing models include alignment with Market Access for value-driven commercial outcomes and alignment with Medical for comprehensive evidence generation and influencing the overall drug development program. Join industry experts and weigh in on this debate: Which structure provides the best “home” for HEOR professionals to shape impactful strategies and deliver desired outcomes for healthcare stakeholders?
Code
089
Topic
Economic Evaluation, Health Technology Assessment, Organizational Practices